Edges in Network
| Network | GSE12093_egf1520 - GSE12093 - SiGN-BN HC+Bootstrap |
| Network Description | The 76-gene Signature Defines High-Risk Patients that Benefit from Adjuvant Tamoxifen Therapy |
| Node | E2F5 |
| Upstream (Parents) |
|---|
| (<<) ARHGEF2 → E2F5 |
| (<<) ATP2A2 → E2F5 |
| (<<) CSNK1A1 → E2F5 |
| (<<) DAZAP2 → E2F5 |
| (<<) HSP90AB1 → E2F5 |
| (<<) HSPA8 → E2F5 |
| (<<) MAPKAPK5 → E2F5 |
| (<<) MYC → E2F5 |
| (<<) POLR1B → E2F5 |
| (<<) PRKCD → E2F5 |
| (<<) RPS12 → E2F5 |
| (<<) SET → E2F5 |
| (<<) SLC25A32 → E2F5 |
| (<<) SMO → E2F5 |
| (<<) TSG101 → E2F5 |
| (<<) TSPAN3 → E2F5 |
| (<<) UBE2N → E2F5 |
| (<<) YWHAZ → E2F5 |
| Downstream (Children) |
|---|
| E2F5 → DSCAM (>>) |
| E2F5 → EFHD2 (>>) |
| E2F5 → FZD6 (>>) |
| E2F5 → GAD1 (>>) |
| E2F5 → HDAC11 (>>) |
| E2F5 → ITGAE (>>) |
| E2F5 → MST1R (>>) |
| E2F5 → NFIX (>>) |
| E2F5 → NUDT6 (>>) |
| E2F5 → PDIA4 (>>) |
| E2F5 → PTK2 (>>) |
| E2F5 → RYK (>>) |
| E2F5 → SCARB1 (>>) |
| E2F5 → SLC25A37 (>>) |
| E2F5 → SMAD3 (>>) |
| E2F5 → SOX9 (>>) |
| E2F5 → SQLE (>>) |
| E2F5 → WNT4 (>>) |
